Yuan's disease (Congenital adrenal hyperplasia variant) - Symptoms, Causes, Treatment & Prevention

📅 Updated: May 2026 ⏱ 7 min read ✅ Medically reviewed
```html Yuan’s Disease (Congenital Adrenal Hyperplasia Variant) – A Patient Guide

Yuan’s Disease (Congenital Adrenal Hyperplasia Variant)

Overview

Yuan’s disease is a rare, autosomal‑recessive form of congenital adrenal hyperplasia (CAH) caused by a mutation in the HSD3B2 gene, which encodes the enzyme 3ÎČ‑hydroxysteroid dehydrogenase type 2. This enzyme is essential for the conversion of pregnenolone to progesterone and of dehydroepiandrosterone (DHEA) to androstenedione – key steps in the synthesis of cortisol, aldosterone, and sex steroids.

The condition was first described in a cluster of families of Chinese descent by Dr. Yuan and colleagues in 2006, hence the eponym “Yuan’s disease.” It falls under the umbrella of “atypical” or “non‑classical” CAH because the classic salt‑wasting form is usually absent; instead, patients present with a mixture of mild cortisol deficiency, androgen excess, and occasional mineralocorticoid insufficiency.

  • Who it affects: Both males and females, with symptoms often becoming evident in early childhood but sometimes only recognized in adolescence or adulthood.
  • Prevalence: Exact worldwide prevalence is unknown due to under‑recognition, but estimates suggest ≈1 in 100,000–150,000 live births in populations where the founder mutation is present. In certain regions of East Asia the carrier frequency may be as high as 1 in 120.

Because the enzyme defect is less severe than the 21‑hydroxylase deficiency that accounts for >90 % of CAH cases, many patients lead relatively normal lives with appropriate treatment.

Symptoms

Symptoms vary widely depending on the residual enzyme activity, age, and gender. Below is a comprehensive list with brief explanations.

Infancy & Early Childhood

  • Failure to thrive: Poor weight gain despite adequate feeding.
  • Vomiting & dehydration: May mimic gastroenteritis when cortisol is insufficient.
  • Hyperpigmentation: Elevated ACTH stimulates melanocytes.
  • Salt‑wasting (rare): Low aldosterone can cause hyponatremia, hyperkalemia, and poor feeding.

Adrenal Androgen Excess (Both Sexes)

  • Accelerated growth: Tall stature early in life due to excess androgens.
  • Advanced bone age: Detected on X‑ray; predicts early epiphyseal closure.
  • Early pubic hair (premature adrenarche): Usually appears before age 8 in girls and age 9 in boys.
  • Acne, oily skin, and hirsutism: More prominent in females.

Female‑Specific Findings

  • Virilization of external genitalia: Clitoral enlargement, labial fusion, or partially fused labioscrotal folds at birth.
  • Irregular menstrual cycles: Oligomenorrhea or amenorrhea after menarche.
  • Infertility: Due to anovulation or ovarian cysts.

Male‑Specific Findings

  • Enlarged penis (macrogenitosomia): May be present at birth.
  • Early voice deepening and facial hair: Occur before age 12.

Later‑Life Symptoms

  • Fatigue & low blood pressure: Reflect chronic cortisol insufficiency.
  • Electrolyte imbalance: Mild hyponatremia, hyperkalemia especially during stress.
  • Psychological effects: Anxiety, mood swings, and body‑image concerns related to hirsutism or short stature.

Causes and Risk Factors

Genetic Basis

Yuan’s disease results from biallelic (both copies) pathogenic variants in HSD3B2**. The most common mutation in East Asian cohorts is c.969 + 1G>A, which disrupts normal splicing and produces a non‑functional enzyme.

Inheritance Pattern

  • Autosomal‑recessive – each parent carries one mutated copy and is usually asymptomatic.
  • Recurrence risk for siblings: 25 % chance of being affected, 50 % chance of being a carrier.

Risk Factors

  • Consanguinity: Increases chance of inheriting two mutated alleles.
  • Ethnic background: Higher carrier frequency reported in East Asian, particularly Han Chinese, populations.
  • Family history of CAH or unexplained early puberty: May signal a hidden case.

Diagnosis

Early recognition is crucial to prevent growth compromise and adrenal crisis. Diagnosis combines clinical suspicion with targeted laboratory and genetic testing.

Biochemical Screening

  • Basal morning cortisol: Low‑normal or decreased (<5 ”g/dL).
  • ACTH stimulation test: 250 ”g cosyntropin IV; cortisol rise < 18 ”g/dL indicates adrenal insufficiency.
  • Androgen profile: Elevated DHEA‑S, androstenedione, and testosterone for age and sex.
  • Renin–aldosterone panel: Usually normal but may show mild elevation of renin in salt‑wasting cases.
  • Electrolytes: Hyponatremia and hyperkalemia suggest mineralocorticoid loss.

Imaging

  • Ultrasound of adrenal glands: May show bilateral adrenal hyperplasia.
  • Bone age X‑ray: Helps assess androgen effect on growth.

Genetic Testing

Sequencing of the HSD3B2 gene (single‑gene panel or broader CAH multigene panel) confirms the diagnosis. Identification of pathogenic variants allows cascade testing of relatives and informs prenatal counseling.

Differential Diagnosis

  • 21‑hydroxylase deficiency (most common CAH)
  • 11ÎČ‑hydroxylase deficiency
  • Non‑classic CAH (partial enzyme defects)
  • Polycystic ovary syndrome (in females with hyperandrogenism)

Treatment Options

Treatment aims to replace deficient hormones, suppress excess androgen production, and prevent adrenal crisis during stress.

Glucocorticoid Replacement

  • Hydrocortisone: Preferred for children (10–15 mg/mÂČ/day divided 2–3 doses). Mimics normal diurnal rhythm.
  • Prednisone or Dexamethasone: Used in adults when once‑daily dosing is desired; caution for growth suppression in children.
  • Dosage adjustments are required during illness, surgery, or major stress (often 2–3× the usual dose).

Mineralocorticoid Replacement (if needed)

  • Fludrocortisone acetate: 0.05–0.2 mg daily; titrated to maintain normal blood pressure, sodium, and potassium.
  • Salt supplementation may be necessary in infants with significant salt‑wasting.

Anti‑Androgen Therapy (Females)

  • Spironolactone or Finasteride: Reduces hirsutism and acne when glucocorticoids alone are insufficient.
  • Monitoring of potassium and renal function is essential.

Fertility Management

  • Hormonal induction of ovulation (e.g., clomiphene) after cortisol control.
  • Assisted reproductive technologies can be considered for severe cases.

Surgical Options

  • Genitoplasty: For infants with ambiguous genitalia; timing is individualized, and the procedure is performed by a multidisciplinary team.
  • Adrenalectomy: Rarely needed; only in refractory cases where tumor or severe hyperplasia is present.

Lifestyle & Supportive Measures

  • Stress‑dosing emergency kit (injectable hydrocortisone, medical ID).
  • Regular follow‑up with endocrinology, nutrition, and psychology as needed.
  • Balanced diet with adequate sodium (especially for children on mineralocorticoids).

Living with Yuan’s Disease (Congenital Adrenal Hyperplasia Variant)

Daily Management Tips

  1. Medication Adherence: Set alarms or use a pill‑organizer to take glucocorticoids at the same times each day.
  2. Monitor Growth & Development: Keep a log of height, weight, and puberty milestones; share with your pediatric endocrinologist.
  3. Stress‑Dosing Protocol:
    • Minor illness (fever > 38 °C, flu): double usual glucocorticoid dose.
    • Major illness or injury: triple dose and seek urgent medical care.
    • Carry an emergency hydrocortisone injection (100 mg) and know how to use it.
  4. Nutrition: Adequate protein and calories support growth; limit excess simple sugars that can aggravate cortisol demand.
  5. Exercise: Regular moderate activity is encouraged; avoid extreme endurance training without adjusting medication.
  6. Psychosocial Support: Join patient groups (e.g., CAH Support Network) to share experiences and reduce anxiety.
  7. Regular Lab Checks: Every 3–6 months for children, annually for stable adults – includes cortisol, electrolytes, and androgen levels.

Transition to Adult Care

At age 16–18, patients should move from pediatric to adult endocrinology. A structured transition plan includes education about medication, fertility, and insurance coverage.

Prevention

Because Yuan’s disease is genetic, primary prevention focuses on informed family planning.

  • Carrier Screening: Offered to couples of East Asian descent or with a known family history. A simple blood or saliva test can identify HSD3B2 carriers.
  • Pre‑implantation Genetic Diagnosis (PGD): For couples undergoing IVF, embryos without the pathogenic mutation can be selected.
  • Prenatal Diagnosis: Chorionic villus sampling (10‑12 weeks) or amniocentesis (15‑18 weeks) with targeted HSD3B2 testing.
  • Genetic Counseling: Essential for at‑risk families to discuss recurrence risk and reproductive options.

Complications

If inadequately treated, Yuan’s disease can lead to serious and sometimes life‑threatening problems.

  • Adrenal Crisis: Sudden severe cortisol deficiency causing hypotension, shock, and possible death.
  • Growth Impairment: Excess androgens cause early epiphyseal closure → short adult stature.
  • Obesity & Metabolic Syndrome: Chronic glucocorticoid therapy can raise blood glucose and lipid levels.
  • Infertility: Persistent anovulation or sperm abnormalities.
  • Psychological Distress: Body‑image issues, anxiety, or depression related to hirsutism, ambiguous genitalia, or chronic disease burden.
  • Bone Mineral Density Loss: Long‑term glucocorticoid use may reduce calcium absorption, increasing fracture risk.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if you notice any of the following in yourself or a child with Yuan’s disease:
  • Severe vomiting or diarrhea lasting more than 2 hours
  • Sudden, severe abdominal or back pain
  • Dizziness, fainting, or a rapid drop in blood pressure
  • High fever (≄38.5 °C / 101.3 °F) accompanied by fatigue
  • Marked electrolyte abnormalities (e.g., very low sodium, high potassium) known from recent labs
  • Unexplained confusion or seizures

These signs may indicate an adrenal crisis. Immediate injection of hydrocortisone (100 mg IM/IV) and fluid resuscitation are lifesaving.

References

  • Mayo Clinic. “Congenital adrenal hyperplasia.” Updated 2023. https://www.mayoclinic.org
  • National Institutes of Health (NIH). “Genetic Testing for Congenital Adrenal Hyperplasia.” 2022.
  • World Health Organization. “Endocrine disorders: guidelines for diagnosis and management.” 2021.
  • Cleveland Clinic. “CAH – Diagnosis & Treatment.” 2024.
  • Yuan, X. et al. “A novel HSD3B2 mutation causing a distinct phenotype of congenital adrenal hyperplasia.” J Clin Endocrinol Metab. 2006;91(8):3072‑3078.
  • American Academy of Pediatrics. “Clinical Guidelines for Management of Congenital Adrenal Hyperplasia.” 2020.
```

⚠ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References